Literature DB >> 32593828

Ivermectin confers its cytotoxic effects by inducing AMPK/mTOR-mediated autophagy and DNA damage.

Ping Zhang1, Hongfei Ni1, Yang Zhang1, Wenping Xu1, Jufang Gao2, Jiagao Cheng1, Liming Tao3.   

Abstract

Ivermectin (IVM), a broad-spectrum antiparasitic drug, is widely used in agriculture and animal husbandry. Due to widespread use and little metabolism in animals, the toxicity of IVM has received increasing attention. The accumulation of IVM in animal tissues and the excretion of urine and feces in the environment is the major source of potential toxicity. Human consumption of meat or milk contaminated with livestock can result in exposure to high levels of IVM exposure. The aim of this study was to reveal the cytotoxic mechanism of IVM in model cell HeLa in vitro, in order to provide a theoretical basis for the safe and rational use of IVM. Here we observed the γH2AX and 8-oxodG foci to detect the DNA damage in HeLa cells. As expected, we found that IVM can induce oxidative double-stranded damage in HeLa cells, indicating that IVM has potential genotoxicity to human health. In addition, we observed the formation of LC3-B in HeLa cells, the accumulation of Beclin1, the degradation of p62 and the activation of the AMPK/mTOR signal transduction pathway. This suggests that IVM confers cytotoxicity through autophagy mediated by the AMPK/mTOR signaling pathway. We conclude that IVM produces genotoxicity and cytotoxicity by inducing DNA damage and AMPK/mTOR-mediated autophagy, thereby posing a potential risk to human health.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Accumulated toxicity; Autophagy; Cytotoxicity; DNA damage; Ivermectin

Mesh:

Substances:

Year:  2020        PMID: 32593828     DOI: 10.1016/j.chemosphere.2020.127448

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  4 in total

1.  Ivermectin-Induced Apoptotic Cell Death in Human SH-SY5Y Cells Involves the Activation of Oxidative Stress and Mitochondrial Pathway and Akt/mTOR-Pathway-Mediated Autophagy.

Authors:  Yuan Zhang; Tun Sun; Meng Li; Yanling Lin; Yue Liu; Shusheng Tang; Chongshan Dai
Journal:  Antioxidants (Basel)       Date:  2022-05-05

Review 2.  Autophagy Modulators in Coronavirus Diseases: A Double Strike in Viral Burden and Inflammation.

Authors:  Rafael Cardoso Maciel Costa Silva; Jhones Sousa Ribeiro; Gustavo Peixoto Duarte da Silva; Luciana Jesus da Costa; Leonardo Holanda Travassos
Journal:  Front Cell Infect Microbiol       Date:  2022-03-24       Impact factor: 6.073

Review 3.  Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.

Authors:  Theo Rein
Journal:  J Cell Biochem       Date:  2021-10-20       Impact factor: 4.480

4.  Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.

Authors:  Ali A Samaha; Hussein Mouawia; Mirna Fawaz; Hamad Hassan; Ali Salami; Ali Al Bazzal; Hamid Bou Saab; Mohamed Al-Wakeel; Ahmad Alsaabi; Mohamad Chouman; Mahmoud Al Moussawi; Hassan Ayoub; Ali Raad; Ola Hajjeh; Ali H Eid; Houssam Raad
Journal:  Viruses       Date:  2021-05-26       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.